Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial. [electronic resource] by
- Krueger, James G
- Ferris, Laura K
- Menter, Alan
- Wagner, Frank
- White, Alexander
- Visvanathan, Sudha
- Lalovic, Bojan
- Aslanyan, Stella
- Wang, Elaine E L
- Hall, David
- Solinger, Alan
- Padula, Steven
- Scholl, Paul
Producer: 20151005
In:
The Journal of allergy and clinical immunology vol. 136
Availability: No items available.
|